USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinson’s Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors and other pharamcolgical approaches for current global interest. This research service does not cover vaccines. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for Parkinson’s Disease therapeutics. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology.
Executive Summary
Recent Market Developments
Companies to Watch
Key Trends in Parkinson’s Disease Therapeutics
Methodology and Scope
Introduction
Global Prevalence of Parkinson’s Disease by Country
Global Incidence of Parkinson’s Disease by Country
Market Overview—Segmentation by Types of Therapeutics
Market Overview—Segmentation Illustrated
Market Overview—Segmentation Illustrated (continued)
Overview of Market Opportunities
Competitive Landscape—Marketed Products and Products in Development
Marketed Product Synopsis—Parkinson’s Disease Therapeutics
Marketed Product Synopsis—Parkinson’s Disease Therapeutics (continued)
Marketed Product Synopsis—Parkinson’s Disease Therapeutics (continued)
Marketed Product Synopsis—Parkinson’s Disease Therapeutics (continued)
Pipeline Synopsis—Parkinson’s Disease Therapeutics
Pipeline Synopsis—Parkinson’s Disease Therapeutics- Continued
Pipeline Synopsis—Parkinson’s Disease Therapeutics- Continued
Pipeline Synopsis—Parkinson’s Disease Therapeutics- Continued
Parkinson’s Disease Therapeutics Market—Competitive Landscape: Major Ongoing Trials
Competitive Landscape—Projected Launch Timeline for Key Pipeline Drugs
Competitive Landscape—Company Assets by Drug Pipeline Class
Key Marketed Products Dashboard: Stalevo (Carbidopa-Levodopa-Entacapone)—Orion Corporation
Key Marketed Products Dashboard: Sinemet (carbidopa-levodopa)—Merck & Co
Key Marketed Products Dashboard: Azilect (Rasagiline) By TEVA Pharmaceuticals
Key Marketed Products Dashboard: Zelapar (Selagiline) By Valeant Pharmaceuticals
Key Marketed Products Dashboard: Mirapex (Pramipexole) By Boehringer Ingelheim
Key Marketed Products Dashboard: Neupro (Rotigotine) By UCB Inc. and Schwarz Pharma
Key Marketed Products Dashboard: Requip (Ropinirole) By Glaxo SmithKline
Key Phase 3 Products Dashboard:Nouriast® (Istradefylline) By Kyowa Hakko Kirin
Key Phase 2 Products Dashboard:Ampyra® (dalfampridine) By Acorda Therapeutics
Key Phase 3 Products Dashboard:Duodopa® (sinemet) By AbbVie Pharmaceutical
Conclusion
Conclusions (Continued)
Legal Disclaimer
Decision Support Database—Global Population with Parkinson’s Disease
Decision Support Database—Global Population with Parkinson’s Disease (continued)
Who is Frost & Sullivan
What Makes Us Unique
TEAM Methodology
Our Global Footprint 40+ Offices
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: Facility Management in Malaysia, 2026
Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...
17 Sep 2026 | Global | Market Research
Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029
The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: ASEAN Warehouse Automation System Providers, 2026
Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...
16 Sep 2026 | North America | Customer Research
US Automotive Technicians’ Choice Survey, 2025
The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...
16 Sep 2026 | Global | Market Research
Apple Performance Tracker, Q1 2026
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| WIP Number | MA14-01-00-00-00 |
| Is Prebook | No |
Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market
$3,950.00
Special Price $2,962.50 save 25 %